|November 4, 2012|
|09:55 EDT||SNY, SNY, SNY, REGN, REGN, REGN||Regeneron to co-host a conference call with Sanofi |
Regeneron and Sanofi co-host a conference call during the upcoming American Heart Association's Scientific Sessions which will focus on the LDL cholesterol-lowering PCSK9 Antibody (SAR236553/ REG727) on November 5 at 10:15 am. Webcast Link
News For SNY;REGN From The Last 14 Days
|April 15, 2015|
|11:56 EDT||SNY||Sanofi initiated with a Buy at Societe Generale|
Subscribe for More Information
|07:41 EDT||SNY||EBD Group to hold a forum|
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
|April 10, 2015|
|07:17 EDT||REGN||Expert very bullish on outlook for Regeneron Eylea, says RBC Capital|
RBC Capital reports that a retina expert with whom it spoke was "very bullish" on the outlook for Regeneron's Eylea, not just in DME but also in wet AMD. The firm says the expert's positive outlook was sparked by recently presented Protocol T data. RBC continues to believe that Eylea could beat guidance this year, while Phase III programs could boost the stock. RBC keeps a $490 price target and Outperform rating on the shares.
|April 7, 2015|
|07:14 EDT||SNY||Eyeforpharma to hold a summit|
Philadelphia 2015 Commercial Pharma Summit is being held in Philadelphia on April 7-8.